Special endpoint and product specific considerations in pharmaceutical acceptable daily exposure derivation. [electronic resource]
Producer: 20170309Description: S79-93 p. digitalISSN:- 1096-0295
- Animals
- Dose-Response Relationship, Drug
- Drug Contamination -- prevention & control
- Drug Hypersensitivity -- immunology
- Drug Industry -- legislation & jurisprudence
- Drug-Related Side Effects and Adverse Reactions -- immunology
- Guidelines as Topic
- Health Policy
- Humans
- Mutagenicity Tests
- No-Observed-Adverse-Effect Level
- Occupational Exposure -- adverse effects
- Occupational Health -- legislation & jurisprudence
- Pharmaceutical Preparations -- classification
- Pharmacokinetics
- Policy Making
- Proteins -- adverse effects
- Risk Assessment
- Toxicity Tests -- methods
- Toxicokinetics
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.